| Dr Ronald Low, MD | |
|
1102 Saint Marys Rd, Geary Community Hospital Emergency Department, Junction City, KS 66441-4139 | |
| (785) 238-4131 | |
| Not Available |
| Full Name | Dr Ronald Low |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1102 Saint Marys Rd, Junction City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013942937 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 194372 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Low, MD 77 Bloomingdale Rd, Staten Island, NY 10309-2815 Ph: (718) 967-3110 | Dr Ronald Low, MD 1102 Saint Marys Rd, Geary Community Hospital Emergency Department, Junction City, KS 66441-4139 Ph: (785) 238-4131 |
News Archive
Icagen, Inc. reported today its financial results and operational highlights for the first quarter ended March 31, 2010. For the first quarter of 2010, the Company reported revenues of $1.5 million and a net loss of $3.2 million. As of March 31, 2010, the Company's cash and cash equivalents totaled $14.3 million.
For the past decade or so, we've been hearing repeatedly about an "innovation" crisis in pharmaceuticals. Big Pharma and its friends in government and elsewhere have claimed that research into new drugs is slowing down, primarily, they say, because of onerous regulatory demands
Meniscal tears of the knee (aka, torn cartilage) are extraordinarily prevalent and become universally present as one ages. Treatment often involves surgery, but is surgery the best option? Not necessarily according to scientific evidence presented in the newly published 3rd edition of the American College of Occupational and Environmental Medicine's Occupational Medicine Practice Guidelines, knee disorders chapter.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
› Verified 7 days ago
Dr. Jason N Butler, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1102 Saint Marys Rd, Junction City, KS 66441 Phone: 785-238-0325 | |
Dr. Marc Felts, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1110 Saint Marys Rd, Suite 400, Junction City, KS 66441 Phone: 785-762-2585 | |
Dean E Karas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1102 Saint Marys Rd, Junction City, KS 66441 Phone: 785-238-4444 Fax: 785-762-5133 | |
Dr. Keir Gaven Swisher, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1102 Saint Marys Rd, Junction City, KS 66441 Phone: 785-238-0325 |